NCT06927024View on ClinicalTrials.gov

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Chronic Kidney Diseases
Interventions
DEVICE

Active taVNS

Active taVNS delivered via the TENS Device 7000.

DEVICE

Sham taVNS

Sham taVNS delivered via the TENS Device 7000.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

NYU Langone Health

OTHER

NCT06927024 - Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD) | Biotech Hunter | Biotech Hunter